Side by side
Intelligencia AI vs Stocknews AI
2 tools side by side, on the data we have on file for each.
| Intelligencia AI | Stocknews AI | |
|---|---|---|
| Price | Free | Free |
| Free tier | Yes | No |
| Our score | 4.0 / 5 | 3.7 / 5 |
| Our line on it | Predict drug success with AI, but relies on comprehensive data inputs. | Stocknews AI spots hard-to-track news sources instantly. Best for analysts. |
| Best for | Pharma companies looking to de-risk clinical development. | Analysts and data scientists |
| Not for | Teams needing datasets for niche therapeutic areas | Detailed manual analysts |
| Platforms | Web, macOS, Windows | Web |
| Real-time reporting | Yes° | Yes° |
| Category | Data and analytics | Data and analytics |
| Best described as | Business Intelligence | Business Intelligence |
| Last checked | 5 Oct 2026 | 5 Oct 2026 |
° Read from the vendor's own pages; not yet confirmed by a reviewer.
We have not written a verdict for this pairing
The table above is the data on each tool's own page, side by side. A written head-to-head goes further: it names a winner per use case and says who should stay where they are. Those are written by a reviewer, pair by pair, so this one may not have its verdict yet.